Sign in with Google
Agency Queries
Join our community on Telegram!
Join the biggest community of Pharma students and professionals.
Agency Queries are formal questions or requests for clarification issued by a regulatory authority during the scientific assessment of a pharmaceutical submission. They arise when reviewers identify gaps, inconsistencies, insufficient justification, or areas requiring additional explanation within the submitted dossier.
These queries are a routine and structured part of regulatory review and do not automatically indicate rejection. Authorities such as the U.S. Food and Drug Administration and the European Medicines Agency use agency queries to ensure that decisions are based on complete and scientifically robust information.
Regulatory Context
When a company submits an NDA, ANDA, BLA, MAA, supplement, or variation, the authority conducts a multidisciplinary review covering quality, nonclinical, clinical, pharmacovigilance, and labeling aspects. If reviewers find deficiencies or require clarification, they issue agency queries within defined review timelines.
In the United States, queries may appear as Information Requests, Discipline Review Letters, or be incorporated into a Complete Response Letter. In the European centralized procedure, formal questions are typically issued at Day 120 and Day 180 of the review clock.
Purpose of Agency Queries
The objective of agency queries is to protect public health by ensuring that all regulatory decisions are based on complete, accurate, and scientifically justified data. Queries allow regulators to seek clarification before approving or rejecting an application.
Types of Agency Queries
Agency queries can be categorized based on their technical focus.
| Category | Nature of Query | Example |
|---|---|---|
| Quality (CMC) | Manufacturing or stability concerns | Request for additional validation data |
| Clinical | Efficacy or statistical clarification | Justification of subgroup analysis |
| Safety | Risk evaluation concerns | Clarification of serious adverse event data |
| Labeling | Wording or claim justification | Narrowing of indication statement |
| Bioequivalence | PK analysis issues | Request for additional statistical explanation |
| Administrative | Documentation gaps | Missing signed application form |
Classification by Severity
Not all queries carry the same regulatory weight. Some are minor clarifications, while others represent major objections that could prevent approval.
| Level | Impact on Approval |
|---|---|
| Minor Clarification | Low risk, typically resolved quickly |
| Major Objection | Requires substantial justification or new data |
| Critical Deficiency | May lead to refusal if unresolved |
Lifecycle Occurrence
Agency queries can arise during:
Initial marketing authorization review
Post-approval supplement evaluation
Variation assessment
Renewal application review
Inspection follow-up
Response Strategy
Responding to agency queries requires a structured and coordinated approach involving regulatory affairs, medical writing, quality assurance, clinical teams, and pharmacovigilance.
A standard response approach includes:
Clear restatement of the authority question
Direct and scientifically supported answer
Reference to specific CTD sections
Provision of revised documents when required
Risk assessment if applicable
Timelines and Review Clock
Authorities typically pause or stop the review clock while waiting for responses. Delayed or incomplete responses can extend approval timelines. In some cases, insufficient responses may result in additional rounds of queries.
Impact on Labeling
Agency queries frequently affect labeling. Authorities may request removal of unsupported promotional language, clarification of safety warnings, adjustment of dosage recommendations, or alignment of benefit–risk statements.
Inspection and Compliance Perspective
Regulators may review historical agency queries and company responses during inspections to evaluate scientific rigor and transparency. Repeated weak justifications can impact regulatory credibility.
Strategic Importance
Agency queries are part of regulatory dialogue and reflect active scientific engagement between the sponsor and the authority. Effective handling of queries demonstrates regulatory maturity, strong documentation systems, and cross-functional coordination.
Agency Queries therefore represent a structured mechanism within regulatory review that ensures submitted applications meet scientific, safety, and compliance standards before approval.
